Australian Healthcare Most Popular Stocks

Clever Culture Systems

Market Cap: AU$67.6m

Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, China, Netherlands, and Germany.

BlinkLab

Market Cap: AU$67.0m

Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.

Beamtree Holdings

Market Cap: AU$66.8m

Provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.

Doctor Care Anywhere Group

Market Cap: AU$58.7m

Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.

CleanSpace Holdings

Market Cap: AU$56.0m

Designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally.

VIP Gloves

Market Cap: AU$55.1m

Engages in the production and trading of nitrile gloves in Malaysia.

Micro-X

Market Cap: AU$54.1m

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Compumedics

Market Cap: AU$52.8m

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.

Microba Life Sciences

Market Cap: AU$51.8m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

dorsaVi

Market Cap: AU$50.6m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

Nova Eye Medical

Market Cap: AU$47.0m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

Vitasora Health

Market Cap: AU$44.7m

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.

INOVIQ

Market Cap: AU$44.7m

Develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

Next Science

Market Cap: AU$43.9m

Engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.

CurveBeam AI

Market Cap: AU$43.5m

Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America and internationally.

HeraMED

Market Cap: AU$41.6m

A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.

Enlitic

Market Cap: AU$27.5m

Operates in the healthcare sector in the United States, Europe, and Japan.

Rhythm Biosciences

Market Cap: AU$26.8m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

MedAdvisor

Market Cap: AU$26.3m

Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.

Atomo Diagnostics

Market Cap: AU$24.3m

Engages in the development and sale of medical devices worldwide.

Advanced Health Intelligence

Market Cap: AU$22.6m

Operates as a mobile application and technology development company in Australia and internationally.

ReNerve

Market Cap: AU$18.0m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

Neurotech International

Market Cap: AU$17.8m

A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

Intelicare Holdings

Market Cap: AU$17.7m

Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.

Resonance Health

Market Cap: AU$17.6m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa.

CONNEQT Health

Market Cap: AU$17.6m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

ImExHS

Market Cap: AU$14.3m

Offers cloud-based medical imaging solutions in Australia and internationally.

Crigen Resources

Market Cap: AU$13.5m

Operates as a health and wellness company in Australia.

Control Bionics

Market Cap: AU$11.4m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Visionflex Group

Market Cap: AU$10.1m

Together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia.

Imagion Biosystems

Market Cap: AU$8.9m

Provides medical imaging technologies using magnetic resonance.

HITIQ

Market Cap: AU$8.0m

Develops and commercializes concussion management technology in Oceania.

Adherium

Market Cap: AU$7.5m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

TrivarX

Market Cap: AU$6.2m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

InhaleRx

Market Cap: AU$6.0m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

Global Health

Market Cap: AU$5.9m

Provides digital health solutions for the healthcare industry in Australia.